Laney Harney
About Laney Harney
Laney Harney is the Regional Associate Director of Myeloid MSLs, West at Bristol Myers Squibb, with extensive experience in oncology and hematologic malignancies.
Current Role at Bristol Myers Squibb
Laney Harney serves as the Regional Associate Director for Myeloid MSLs in the Western region at Bristol Myers Squibb. She started this role on May 1, 2021. In this position, she plays a crucial role in placing clinical trials at key cancer centers throughout the western United States. Additionally, she provides education, data updates, REMS training (CAR-T), and study opportunities to medical experts and their staff.
Previous Experience at Novartis Oncology
Prior to her current role, Laney Harney worked at Novartis Oncology as an Area Scientific Director for 21 years, from 2000 to 2021. Her extensive experience in strategic planning for drug development specifically in hematologic malignancies was key to her role. During her tenure at Novartis Oncology, she contributed significantly to the field and built a solid foundation in pharmaceutical sciences and oncology.
Educational Background in Pharmacy
Laney Harney's educational achievements include a Doctor of Pharmacy (PharmD) from the University of California, San Francisco, completed from 1989 to 1993. At UCSF, she specialized in Clinical Pharmacy, Hematology-Oncology Pharmacy, and Investigational Drug Pharmacy. She also holds a Bachelor of Science degree in Pharmacology from UC Santa Barbara. Her rigorous academic background has been vital to her career in the pharmaceutical and oncology fields.
Early Career in Medical Affairs and Liaison Roles
Laney Harney began her professional journey at SEQUUS Pharmaceuticals as a Medical Science Liaison for 2 years from 1997 to 1999. She then joined ALZA Corporation as Associate Director of Medical Affairs for 1 year from 1998 to 1999. These early roles provided her with valuable experience that she later applied in more senior positions throughout her career.
Strategic Planning and Clinical Trial Placement
With extensive experience in strategic planning for drug development, particularly in hematologic malignancies, Laney Harney plays a pivotal role in placing clinical trials at key cancer centers in the western US. Her strategic acumen ensures that promising new treatments are effectively integrated into clinical practice settings, benefiting both patients and medical professionals.